Creabilis SA Announces Headline Results of Its Phase 2b Trial of Topical TrkA Kinase Inhibitor CT327
5/10/2013 9:43:08 AM
More...
|
Creabilis SA Appoints Dr Simon Russell as Chief Business Officer
5/3/2012 11:18:50 AM
More...
|
Creabilis SA Announces Start of Phase IIb Trial of TrkA Kinase Inhibitor CT327 in Psoriasis
2/29/2012 10:43:51 AM
More...
|
Creabilis SA Raises $20 Million in Series B Fundraising Round
10/4/2011 6:37:23 AM
More...
|
Creabilis SA Expands Senior Management Team
8/18/2011 6:05:47 AM
More...
|